Journals / Gülhane Tıp Dergisi / 2004 / Cilt: 46 - Sayı: 3

Fibrinogen level utilisation as a cardiovascular risk factor for atherosclerosis treatment and follow up

Kardiovasküler risk faktörü olarak fibrinojen'in ateroskleroz tedavi ve takibinde kullanımı

Pages
232–237
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

More longitudinal studies with large enough sample size will be needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:One of the major cause of deaths in Turkey arise from myocardial infarction and the leading cause of myocardial infarction is atherosclerosis, which narrows the coronary vessel lumen brings about the acute coronary syndromes.
📊
Key Findings & Data:We investigated the relationship between serum fibrinogen level and the genesis risk of coronary events among 10 year coronary high risk score patients and the fibrinogen response to recovery of adjustable coronary risks and utilisation of fibrinogen level for atherosclerosis treatment and follow up.
💡
Conclusion & Impact:More longitudinal studies with large enough sample size will be needed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Risk faktörleri · Ateroskleroz · İzleme çalışmaları

Abstract

One of the major cause of deaths in Turkey arise from myocardial infarction and the leading cause of myocardial infarction is atherosclerosis, which narrows the coronary vessel lumen brings about the acute coronary syndromes. We investigated the relationship between serum fibrinogen level and the genesis risk of coronary events among 10 year coronary high risk score patients and the fibrinogen response to recovery of adjustable coronary risks and utilisation of fibrinogen level for atherosclerosis treatment and follow up. Plasma fibrinogen level showed a positive statistical correlation with coronary events and increased level was detected regarding with smoking and age (p< 0.001). Plasma fibrinogen level showed a good statistical correlation with abatement of coronary disease risk factors, quitting smoking, loosing weight, regular exercise and low cholesterol diet (p< 0.05). Body mass index, triglyceride, high density cholesterol correlated significantly with fibrinogen level but no correlation was detected between hypertension, total cholesterol and low density cholesterol levels in terms of pretreatment and one year follow up (p<0.05). The efficient atherosclerosis treatment follow up can be made with plasma fibrinogen level during the therapy. The affection of fibrinogen with atherosclerotic risk factors, we concluded to use it as a follow up marker rather than using it as a marker of atherosclerosis progression. More longitudinal studies with large enough sample size will be needed.

Özet

Her yıl Türkiye'de saptanan ölümlerin büyük çoğunluğu, Akut Miyokard İnfarktüsü'nden ortaya çıkmakta olup bu ölümlerin, en önemli nedeni olan ateroskleroz, koroner arter damar lümenini daraltarak akut koroner sendromlara neden olmaktadır. Bu çalışmada, 10 yıllık koroner olay meydana gelme risk skoru yüksek olan vakalarda, serum fibrinojen seviyesi ile koroner olay meydana gelme riski ve düzeltilebilir koroner risk faktörlerindeki iyileşmeye fibrinojen cevabı ile bunun ateroskleroz takibinde kullanılabilirliğini araştırdık. Plazma, fibrinojen seviyesi ile koroner olay arasında önemli bir korelasyon, sigara içimi ve yaş artışı ile birlikte düzeyinde anlamlı bir artma saptanmıştır (p 0.05). Plazma fibrinojen seviyesi tespiti ateroskleroz tedavisi öncesinde belirlenerek, tedavi etkinliğinin takibi için kullanılabilir. Fibrinojen, özellikle aterosklerotik risk faktörlerinden etkilenmektedir. Bu nedenle yapılan araştırmada, ateroskleroz progresyonundan çok bu hastalığın tedavisinin takibinde kullanılabileceği sonucuna ulaşılmış olup, ileride sadece fibrinojen seviyesinin düşürülmesi ile ilgili daha uzun takip süreli ve daha fazla hasta sayının olduğu klinik çalışmalara da ihtiyaç bulunmaktadır.

🔖

Cite This Article

DEMİRALP, E., ULUSOY, R. E., USLU, M., KIRILMAZ, A., CEBECİ, B. S., ÖZMEN, N., KARDEŞOĞLU, E., US, M. H. (2004). Fibrinogen level utilisation as a cardiovascular risk factor for atherosclerosis treatment and follow up. Gülhane Tıp Dergisi, Cilt: 46 - Sayı: 3, 232–237. https://ajindex.com/articles/226265

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Onat, A., Dursunoglu, D., Sansoy, V.: Relatively high coronary death and event rates in Turkish women. Relation to three major risk factors in five-year follow-up of cohort. Int.J.Cardiol., 29;61(1):69-77 1997 Aug
  2. Davies, M.J.: Pathology of arterial thrombosis. Br.Med.Bull., 1994, 50(4):789-802 Oct
  3. Heinrich, J., Assmann, G.: Fibrinogen and cardiovascular risk. J.Cardiovasc.Risk, 2(3): 197- 205, 1995 Jun
  4. Lowe, G.D.O.: Fibrinogen and cardiovascular disease; Hystorical introduction. European Heart Journal, 16(Suppl.A):2-5, 1995 Mar
  5. International task force for prevention of coronary heart disease: Prevention of coronary heart disease: Scientific background and new clinical guidelines, recommendations of the Europian atherosclerosis society. Nutr.Metab.Cardiovasc.Dis., 2:112, 1992
  6. Dekker, J.M.: Fibrinogen, viscosity and ischemic heart disease. European Heart Disease, 17(12):1780-1, 1996 Dec
  7. Balleisen, L., Bailey, J., Epping, P.H., Schulte, H., Van de Loo, J.: Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I.Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill using and menopause. Throm. Haemost., 30:54(2): 475-9, 1985 Aug
  8. Folsom, A.R., Wu, K.K., Davis, C.E., Conlan, M.G., Sorlie, P.D., Szklo, M.: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis, 91(3):191-205, 1991 Dec
  9. Folsom, A.R., Quamhieh, H.T., Flack, J.M.et al.: Plasma fibrinogen levels and correlates in young adults. Coronary artery risk development in young adults (CARDIA) study. Am.J. Epidemiol., 15;138(12)-1023-1036, 1993 Dec
  10. K., Hense, H.W., Cremer, P., Eberle, E., Keil, U.: Determinants of plasma fibrinogen: relation to body weight, waist to hip ratio, smoking, alcohol, age and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscl. Thromb., 12(7):780-8, 1992 Jul
  11. Lee, A.J., Smith, W.C.S., Lowe, G.D.O., Tunstall- Pedoe, H.: Plasma fibrinogen and coronary risk factors: The Scottish heart health study. J.Clin.Epidemiol., 43(9):913-9, 1990. 236 12. Moller, L., Kristensen, T.S.: Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler.Thromb., 11(2):344-350, 1991 Mar- Apr
  12. Schmidt, M.I., Duncan, B.B., Vigo, A. et al. for the atherosclerosis risk in communities (ARIC) investigators. Detection of undiagnosed diabetes and hyperglycemia states. Diabetes Care, 26(5): 1338-1343, 2003